Fig. 3
From: “Oil-soluble” reversed lipid nanoparticles for oral insulin delivery
Efficacy of ORLN-PHI in lowering blood glucose levels following gavage administration in both healthy and diabetic mice. a Blood glucose-lowering efficacy of various formulations compared with initial levels in healthy mice. b Blood glucose-lowering efficacy of various formulations compared with initial levels in diabetic mice. c Blood glucose-lowering efficacy of various doses of ORLN-PHI (PC/PHI ratio 500:1) in healthy mice. All data are represented as the mean ± SE (n = 6). *p < 0.05